ATE112168T1 - Menschlicher hitzeschock-faktor. - Google Patents

Menschlicher hitzeschock-faktor.

Info

Publication number
ATE112168T1
ATE112168T1 AT89104763T AT89104763T ATE112168T1 AT E112168 T1 ATE112168 T1 AT E112168T1 AT 89104763 T AT89104763 T AT 89104763T AT 89104763 T AT89104763 T AT 89104763T AT E112168 T1 ATE112168 T1 AT E112168T1
Authority
AT
Austria
Prior art keywords
heat shock
shock factor
human heat
compounds
pertains
Prior art date
Application number
AT89104763T
Other languages
English (en)
Inventor
Robert E Kingston
Thomas J Schuetz
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/301,417 external-priority patent/US5137805A/en
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE112168T1 publication Critical patent/ATE112168T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Insects & Arthropods (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
AT89104763T 1988-03-18 1989-03-17 Menschlicher hitzeschock-faktor. ATE112168T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16996588A 1988-03-18 1988-03-18
US07/301,417 US5137805A (en) 1988-03-18 1989-01-25 Method of diagnosing stress condition by specific binding of human heat shock factor

Publications (1)

Publication Number Publication Date
ATE112168T1 true ATE112168T1 (de) 1994-10-15

Family

ID=26865545

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89104763T ATE112168T1 (de) 1988-03-18 1989-03-17 Menschlicher hitzeschock-faktor.

Country Status (11)

Country Link
EP (1) EP0333201B1 (de)
JP (1) JPH03503410A (de)
AT (1) ATE112168T1 (de)
AU (1) AU645243B2 (de)
DE (1) DE68918479T2 (de)
DK (1) DK224790A (de)
ES (1) ES2064375T3 (de)
FI (1) FI904564A0 (de)
IE (1) IE62447B1 (de)
PT (1) PT90019B (de)
WO (1) WO1989008661A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009617A1 (en) * 1990-11-26 1992-06-11 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Cell stress transcriptional factors
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
GB9402857D0 (en) 1994-02-15 1994-04-06 Isis Innovation Targeting gene therapy
EP0995118A1 (de) * 1997-07-10 2000-04-26 Medical Research Council Chaperonenfragmenten
JP3507512B2 (ja) * 1997-09-29 2004-03-15 株式会社エイチ・エス・ピー研究所 熱ショック蛋白質の発現誘導制御物質のスクリーニング方法
DK3578195T5 (da) 2008-06-26 2024-06-10 Zevra Denmark As Anvendelse af Hsp70 som regulator af enzymatisk aktivitet
CA3287846A1 (en) 2016-04-29 2025-11-29 Zevra Denmark A/S Arimoclomol for treating glucocerebrosidase associated disorders
KR20230128462A (ko) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603106A (en) * 1982-02-22 1986-07-29 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
US4701406A (en) * 1984-11-16 1987-10-20 Trustees Of Boston University Assay for the detection of epigenetic toxic (non-genotoxic) substances

Also Published As

Publication number Publication date
EP0333201A3 (en) 1990-05-09
FI904564A7 (fi) 1990-09-17
WO1989008661A1 (en) 1989-09-21
AU3280489A (en) 1989-10-05
EP0333201A2 (de) 1989-09-20
FI904564A0 (fi) 1990-09-17
ES2064375T3 (es) 1995-02-01
DE68918479T2 (de) 1995-03-02
PT90019A (pt) 1990-11-20
DK224790A (da) 1990-11-15
IE62447B1 (en) 1995-02-08
AU645243B2 (en) 1994-01-13
EP0333201B1 (de) 1994-09-28
IE890817L (en) 1989-09-18
PT90019B (pt) 1994-11-30
DK224790D0 (da) 1990-09-18
JPH03503410A (ja) 1991-08-01
DE68918479D1 (de) 1994-11-03

Similar Documents

Publication Publication Date Title
ATE114169T1 (de) Morphogenetisches knochenprotein.
ATE269290T1 (de) Benzoylderivate
FI931370A0 (fi) Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring
NO913785D0 (no) Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister.
EP0397697A4 (en) Quinoline derivatives as antagonists of leukotriene d 4?
EE03057B1 (et) Meetod standardiseeritud, eriti puhta ja teraapiliseks kasutamiseks sobiva inimese von Willebrandi teguri kontsentraadi tööstuslikuks valmistamiseks
NO875378L (no) Fremgangsmaate for fremstilling av granulocyttstimulerendefaktor (polypeptidderivater).
DE3876400D1 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
IL70585A (en) Substituted 4-aminomethylenechromans and-chromenes,their preparation and pharmaceutical compositions containing them
ES2191659T3 (es) Derivados heterociclicos substituidos utiles como inhibidores de la agregacion plaquetaria.
NO871939L (no) Fremgangsmaate for oeket ekspresjon av interleukin-2.
DE68918479D1 (de) Menschlicher Hitzeschock-Faktor.
DK278488A (da) Cycliske peptider med antikoagulerende virkning
DK278588D0 (da) Cycliske peptider med antikoagulerende virkning
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
DK576887D0 (da) Farmaceutiske midler
FI880775A0 (fi) Kraftanlaeggning med foerbraenning av ett braensle i en fluidiserad baedd.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
IT8847920A0 (it) Procedimento per la desolforazione chimico-biologica del carbone
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee